Open access · CC-BY
via OpenAlex
ACE Inhibition with Captopril Retards the Development of Signs of Neurodegeneration in an Animal Model of Alzheimer’s Disease
Said AbdAlla, Andreas Langer, Xuebin Fu, Ursula Quitterer
International Journal of Molecular Sciences · 2013 · ▲ 102 citations
Abstract
Increased generation of reactive oxygen species (ROS) is a significant pathological feature in the brains of patients with Alzheimer's disease (AD). Experimental evidence indicates that inhibition of brain ROS could be beneficial in slowing the neurodegenerative process triggered by amyloid-beta (Abeta) aggregates. The angiotensin II AT1 receptor is a significant source of brain ROS, and AD patients have an increased brain angiotensin-converting enzyme (ACE) level, which could account for an excessive angiotensin-dependent AT1-induced ROS generation. Therefore, we analyzed the impact of ACE inhibition on signs of neurodegeneration of aged Tg2576 mice as a transgenic animal model of AD. Whole genome microarray gene expression profiling and biochemical analyses demonstrated that the centrally active ACE inhibitor captopril normalized the excessive hippocampal ACE activity of AD mice. Concomitantly, the development of signs of neurodegeneration was retarded by six months of captopril treatment. The neuroprotective profile triggered by captopril was accompanied by reduced amyloidogenic processing of the amyloid precursor protein (APP), and decreased hippocampal ROS, which is known to enhance Abeta generation by increased activation of beta- and gamma-secretases. Taken together, our data present strong evidence that ACE inhibition with a widely used cardiovascular drug could interfere with Abeta-dependent neurodegeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms140816917
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
AbdAlla, S., Langer, A., Fu, X., & Quitterer, U. (2013). ACE Inhibition with Captopril Retards the Development of Signs of Neurodegeneration in an Animal Model of Alzheimer’s Disease. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms140816917
Vancouver
AbdAlla S, Langer A, Fu X, Quitterer U. ACE Inhibition with Captopril Retards the Development of Signs of Neurodegeneration in an Animal Model of Alzheimer’s Disease. International Journal of Molecular Sciences. 2013. doi:10.3390/ijms140816917.
BibTeX
@article{said2013ACEInh,
title = {ACE Inhibition with Captopril Retards the Development of Signs of Neurodegeneration in an Animal Model of Alzheimer’s Disease},
author = {Said AbdAlla and Andreas Langer and Xuebin Fu and Ursula Quitterer},
journal = {International Journal of Molecular Sciences},
year = {2013},
doi = {10.3390/ijms140816917},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Antioxidants 2020
Open access · CC-BY
Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration
The Journal of Cell Biology 2011
Open access · OA
Signal transduction by reactive oxygen species
Experimental & Molecular Medicine 2023
Open access · CC-BY
Nicotinamide enhances osteoblast differentiation through activation of the mitochondrial antioxidant defense system
PLoS ONE 2010
Open access · CC-BY
Sirtuin 3, a New Target of PGC-1α, Plays an Important Role in the Suppression of ROS and Mitochondrial Biogenesis
Journal of Translational Science 2016
Open access · CC-BY
The bright side of reactive oxygen species: lifespan extension without cellular demise
Research Journal of Biotechnology 2022
Citation only